What is the diagnosis and appropriate management for an 80-year-old patient with an isolated systolic blood pressure of 163 mm Hg and diastolic pressure of 67 mm Hg?

Isolated Systolic Hypertension

This 80-year-old patient has isolated systolic hypertension (ISH), defined as systolic BP ≥140 mmHg with diastolic BP <90 mmHg, and should be treated with antihypertensive medication targeting a systolic BP <150 mmHg, initiated with either a thiazide diuretic or a long-acting dihydropyridine calcium channel blocker.

Diagnosis

The BP reading of 163/67 mmHg represents isolated systolic hypertension, the predominant form of hypertension in elderly patients. The elevated systolic pressure (163 mmHg) with normal diastolic pressure (67 mmHg) creates a widened pulse pressure (96 mmHg), reflecting arterial stiffness typical of aging 1, 2.

This pattern significantly increases cardiovascular risk, particularly for:

• Stroke
• Coronary heart disease
• Heart failure
• Cardiovascular mortality 1

Treatment Approach

Blood Pressure Target

For this 80-year-old patient, target systolic BP <150 mmHg 2. The 2013 Canadian guidelines specifically recommend this target for the very elderly (≥80 years), based on the landmark HYVET trial which demonstrated reduced stroke, cardiovascular events, and all-cause mortality when treating to 150/80 mmHg in patients ≥80 years 2.

While older 2007 European guidelines suggested targeting <140/90 mmHg if tolerated 1, the more recent and specific evidence from HYVET supports the less aggressive <150 mmHg target for octogenarians 2.

First-Line Medications

Initiate monotherapy with one of these proven agents:

1. Thiazide or thiazide-like diuretic (Grade A evidence) - such as indapamide 1.5 mg sustained-release, which was used successfully in HYVET 2

2. Long-acting dihydropyridine calcium channel blocker (Grade A evidence) - such as amlodipine 2, 1

3. Angiotensin receptor blocker (ARB) (Grade B evidence) - alternative first-line option 2

Do NOT use beta-blockers as first-line therapy for isolated systolic hypertension in patients ≥60 years (Grade A recommendation) 2. They have shown less pronounced cardiovascular protection compared to diuretics in elderly patients 1.

Titration Strategy

• Start with low doses and titrate gradually due to increased risk of adverse effects in very elderly patients 1
• If standard-dose monotherapy fails to achieve target, add a second agent from the first-line options 2
• Many elderly patients require 2+ medications for adequate control 1

Critical Monitoring Considerations

Orthostatic Hypotension Risk

Always measure BP in both seated and standing positions 1. Elderly patients have increased susceptibility to:

• Postural hypotension
• Falls risk
• Cerebral hypoperfusion

The diastolic BP of 67 mmHg requires careful attention during treatment. While some older data suggested concern about diastolic BP <60-70 mmHg, the HYVET trial showed no harm down to diastolic BP of 55 mmHg in patients without coronary disease 1. However, monitor closely as systolic BP is lowered.

Avoid Hypokalemia

If using thiazide diuretics, monitor and prevent hypokalemia (Grade C recommendation) 2, which increases risk of arrhythmias and adverse outcomes.

Evidence Strength

The recommendation is based on:

• HYVET trial (2008): 3845 patients ≥80 years, stopped early for benefit showing 30% stroke reduction, 21% reduction in all-cause mortality with treatment to 144/77 mmHg 2
• Multiple meta-analyses confirming cardiovascular morbidity and mortality reduction in elderly patients with ISH 1
• Specific trial evidence for thiazide diuretics and calcium channel blockers in ISH 1

Common Pitfalls to Avoid

1. Don't withhold treatment based on age alone - benefit extends even beyond 80 years 1
2. Don't target overly aggressive BP goals - <150 mmHg is appropriate for this age group, not <130 mmHg
3. Don't use beta-blockers as first-line - inferior outcomes in elderly ISH 2
4. Don't ignore standing BP measurements - orthostatic hypotension is common and dangerous 1
5. Don't stop successful therapy if patient is tolerating it well, even as they age further 1